Apoptosis or programmed cell death is critical for embryogenesis and tissue homeostasis. Uncontrolled apoptosis leads to different human disorders including immunodeficiency, autoimmune disorder and cancer. Several small molecules that control apoptosis have been identified. Here, we have shown the functional role of triazole derivative (DCPTN-PT) that acts as a potent HDAC inhibitor and mis-express proto onco microRNA (miRNA) bantam. To further understanding the mechanism of action of the molecule in apoptotic pathway, a series of experiments were also performed in Drosophila, a well known model organism in which the nature of human apoptosis is very analogous. DCPTN-PT mis processes bantam microRNA and alters its down regulatory target hid function and cleavage of Caspase-3 which in turn influence components of the mitochondrial apoptotic pathway in Drosophila. However regulatory microRNAs in other pro-apoptotic genes are not altered. Simultaneously, treatment of same molecule also affects the mitochondrial regulatory pathway in human tumour cell lines suggesting its conservative nature between fly and human. It is reasonable to propose that triazole derivative (DCPTN-PT) controls bantam oncomiRNA and increases hid induced apoptosis and is also able to influence mitochondrial apoptotic pathway.
In animal and plant kingdom, developing organs must be correctly patterned during which cell proliferation and apoptosis are coordinated through cell-to-cell communication. Cell proliferation, cell death and pattern formation are three linked important phenomena that occur sequentially during development. Apoptosis contributes to pattern development mainly by removing excess cell population and fine tuning developing structures. In normal cells, apoptosis gets initiated in response to developmental needs, whereas in cancer cells oncogenic signals lead to rapid and uncontrolled cell proliferation resulting in abnormal tissue growth1,2,3,4. How these cellular processes are coordinated during development is poorly understood and still remains a challenging task. In model organism Drosophila, a recently discovered tumour suppressor hippo-signalling pathway controls tissue growth by regulating cell proliferation, apoptosis and cell differentiation5,6,7,8,9,10,11,12,13,14. The hippo pathway acts as a key regulator for controlling organ size. It is often misregulated in various types of cancers. Several components of the hippo signalling pathways have been identified that are highly conserved in human5,6,7,8,9,10,11,12,13,14. In Drosophila, loss of hippo signalling results in overgrowth of tissues as the cells continue to proliferate and also show resistance to pro-apoptotic signals, which eliminates extra cells. So hippo pathway restricts cell proliferation and promotes apoptosis thereby controlling organ growth and tissue size. The bantam gene in Drosophila produces a 21 nt long microRNA (miRNA). Its expression is temporally and spatially controlled in response to patterning cues. It acts as a downstream target of hippo signalling pathway that affects tissue size5,6,7,8,9,10,11,12,13,14,15. Tissues with over expressed bantam miRNA are always larger than normal tissues. The mutated bantam oncomiRNA show an opposite effect. The bantam oncomiRNA prevents apoptosis by controlling downstream pro-apoptotic target head involution defect (hid) and cleavage of Caspase-3 in programmed cell death.
MicroRNAs (miRNAs) are tiny non-coding endogenous RNAs that are involved in gene regulation of many developmental processes. Thousands of miRNAs have been identified in human and other organisms that control nearly 30–40% of the total genes16,17. Processing of miRNA is tightly maintained both temporally and spatially18,19,20,21. During biogenesis, nearly 70 nt long precursor miRNA that forms imperfect hairpin like loop is cleaved by a RNase-III enzyme Dicer1 to form short mature microRNA22,23. Typically, the antisense arm of the hairpin structure (pre-miRNA) recovers as mature miRNA24,25,26,27. Mis-regulation of biogenesis is associated with various diseases including auto-immune disorders and cancer.
Small molecules that target miRNAs are a novel approach to find better therapeutics for cancer. Recently, several in vivo screening platforms have been developed to search small molecules that mis-regulate the processing of microRNA. Though a group of inhibitors have been identified that interfere with microRNA processing28,29, but a platform for chemical analogues that alter oncomi RNA processing in cancer is still missing. Cellular inhibitor that misprocesses oncomiRNA for inducing apoptosis or programmed cell death pathway including endogenous pattern formation has tremendous potentiality as therapeutic agent in cancer. Therefore, development of transgenic model for performing in vivo screening of small molecules provides the platform for understanding the potential insight of apoptotic pathway and their molecular function at every step allowing the only optimal choice for evaluating the functionality of each molecule.
Several inhibitors of apoptosis have been identified and characterized in recent days. Here we have made an attempt to find an inhibitor that specifically targets microRNAs that affect pro-apoptotic genes. Out of our six synthesized HDAC inhibitors (Fig. 1) only compound-2 showed a distinct modulation on bantam microRNA processing but not in other microRNAs that regulate major pro-apoptotic genes reaper, grim and Drice etc. Here we demonstrate the role of bantam microRNA and its pro-apoptotic target hid to understand in-depth action mechanism of compound-2 in controlling apoptosis.
Synthesis and biological evaluation
Numerous compounds having heterocyclic frameworks have been explored to find lead for developing better therapeutics. In continuation, a library of sixty-three 1, 2, 3-triazoles with substitutions at either 4—or 4, 5-positions were synthesized and screened for their biological activity. One of the initial screenings indicated these scaffolds as HDAC inhibitors. To explore the activity, a set of six triazole derivatives were synthesized from azide derived from either advanced, intermediate or the drug itself. We have selected sertraline intermediate and ibuprofen as the azide precursors, keeping the idea that their protein binding properties have been well studied.
The triazoles, 1–6, were synthesized using Huisgen’s 3 + 2 cyclo-addition reaction or ‘click chemistry’. The Cu catalysed reaction lead to the formation of substituted-1, 2, 3-triazoles. Thus, azide precursor obtained from intermediate for sertraline was reacted with alkynes such as phenyl-acetylene, 1-heptyne and acetylene dicarboxylic acid methyl ester in presence of Cu catalyst to obtain the corresponding triazoles 1 to 3, in good yield 88–98%. For the next series, Ibuprofen was converted to an azide derivative, which upon reaction with the similar acetylenes used above resulted in triazoles 4, 5 & 6 in 98, 95 and 94% yields, respectively. All the triazole derivatives 1–6 were fully characterized (For experimental details and spectral data, see Supporting Information).
The triazole derivatives (1–6, Fig. 1) obtained from these azides proved encouraging as they exhibited cell cycle arrest at G1 phase with significant cell death (4 μM conc.) when administered to Drosophila S2 or proliferating tumor HeLa cells (Fig S1-S2).
These compounds (1–6) were further subjected to five dose screening (1 μM, 2 μM. 3 μM, 4 μM and 8 μM) assay followed by cytotoxicity assays. The 1-(4-(3, 4-Dichlorophenyl)-1, 2, 3, 4-tetrahydronaphthalen-1-yl)-4-pentyl-1H-1, 2, 3-triazole (Compound 2, DCPTN-PT)was found the most potent with respect to cell cycle arrest (G1 phase) and induction of apoptosis(50% cell death, 4 μM and 8 μM conc). A proportional increase in the accumulation of cells at sub G1 phase was observed with the increase in the concentration of the compound (Fig S3-S4). Cytotoxicity MTT (MTT = 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium-bromide) assay showed that DCPTN-PT produced nearly 50% death to HeLa cells (IC50 value = HeLa 3.4469 μM) and S2 cells (Drosophila melanogaster) when administered at a concentration of 4 μM (Fig S1-S2).
HDACs have shown to be promising targets for cancer as they regulate transcription and triazole scaffolds have shown to play some role as HDAC inhibitors30. To test whether the triazole scaffold in the compound produce any inhibitory effect on HDAC proteins, series of quantitative western blots were performed. Human cervical cancer cells (HeLa) and Drosophila S2 cells were treated with different concentration of DCPTN-PT compound (1–4 μM) for 72 hours followed by HDAC estimation. Untreated cells served as control. The mean ratios of HDAC proteins relative to ß-Actin protein were measured in three independent assays and plotted in bar histogram. It was found that all four HDACs (HDAC 1, 2, 3 and 8) were reduced consistently upon treatment of HeLa cells with DCPTN-PT. Therefore, DCPTN-PT treatment produced a significant reduction of HDAC 1, 2, 3 and 8 proteins in HeLa cells (Fig. 2A).
To see whether a similar effect on HDAC inhibition occurs in live model organism also, Drosophila larvae were allowed to feed on culture media containing the compound DCPTN-PT (12 μM in 3 ml food media). Western blots were performed with proteins isolated from unfed and compound fed larvae to examine the effect on HDACs. A similar level of reduction of HDAC1 was found in live Drosophila larvae after feeding on the compound in the culture medium (12 μM in 3 ml food media) (Fig. 2A). Therefore, DCPTN-PT acts as a potential HDAC inhibitor both in human tumour cells (HeLa) and Drosophila larvae in vivo (Fig. 2B). Overall these findings through in vitro and in vivo assays suggest that DCPTN-PT acts as a potent HDAC inhibitor.
HDAC inhibitors are known to enhance apoptosis, growth arrest and differentiation31. They have positive effect on tumour suppressor pathway32,33. In this study, we evaluated the role of this newly synthesized HDAC inhibitor (DCPTN-PT) that induces apoptosis pathway in the in vivo model Drosophila.
Drosophila model organism has several advantages. Its rapid life cycle allow extensive studies with transgenics for several generations. Moreover, human oncomiRNA are extremely analogous to Drosophila34.
Apoptosis symptoms and screening for pro apoptotic gene regulation
To investigate generalized apoptosis features, the DCPTN-PT treated S2 cells were analyzed by conventional TUNEL assay. The assay analyzed different apoptosis signatures including chromatin condensation, DNA fragmentation, cellular shrinkage and blebbing etc. These results showed that DNA fragmentation was more prominent when S2 cells were administered with 8 μM of DCPTN-PT compound compared to untreated controls (Fig. 3A). The DNA fragmentation as seen by TUNEL assay was concentration dependent. At 4 μM concentration of DCPTN-PT, the fragmentation was lesser than what was observed at 8 μM of compound in each nucleus of Drosophila S2 cell. However the precursor molecules traizole did not induce DNA fragmentation at similar intensity.
Micro RNAs play a role in cancer progression by regulating different pathways of genes that affect apoptosis such as p53, myc etc. Since DCPTN-PT is a potent molecule in the process of apoptotic pathways, the regulatory microRNA (miR) elements of major pro-apoptotic proteins were tested. A novel transgenic Drosophila approach was employed. The transgenic construct (micro RNA line) expresses Enhanced Green Fluorescent Protein (EGFP) under the control of tubulin promoter. The construct is fused with two to three complete micro RNA target sequences at the 3′UTR. A comparable construct without miRNA target sequences at the same gene end served as control (control sensor). Three transgenic constructs each carrying microRNA coupling sequences that are linked to endogenous regulatory domains at the 3′UTR of three different pro-apoptotic genes reaper, grim and drice were screened. Rearing of larvae from each of three different transgenic stocks in DCPTN-PT containing media did not produce any enhancement of the expression of reporter EGFP relative to control sensor (Fig. 3B–D). Therefore, feeding of the DCPTN-PT containing culture media did not depress the regulatory microRNAs (miR-2, miR-13 and miR-14) that control the translation of three pro-apoptotic host genes (miR-2 and miR-13 targets rpr, grim and miR-14 targets Drice), suggesting that DCPTN-PT compound is not an inhibitor of all proapoptotic genes but very specific to oncomiR bantam.
The bantam miRNA assay in transgenic fly
Drosophila bantam gene encodes a 21 nucleotide miRNA that promotes cell proliferation and reduces apoptosis. It is interrelated with tumour suppressor hippo pathway and hid induced apoptosis pathway in cancer. Endogenous removal of the bantam gene enhances hid induced apoptosis15. Therefore hid pro apoptotic gene acts as a target for regulation by 21 nucleotide bantam miRNA. This study not only allows the understanding of mechanism of action of the molecule in the apoptotic pathway, but also provides a unique platform for in vivo screening of molecules that induces apoptosis for developing cancer therapeutics. Based on the modulation of apoptotic signature and non significant effect on major pro-apoptotic genes, we tested, whether DCPTN-PT mis-expresses bantam oncomiRNA or not. We fed separate batches of larvae with food containing DCPTN-PT (12 μM in 3 ml food).These larvae carried either a control or bantam miRNA transgenic construct. Wild type Drosophila larvae were also fed with the same concentration of DCPTN-PT that serves as control. Moreover, a construct carrying a large deletion of the chromosomal fragment of the bantam endogenous locus was used as null allele (bantamΔ1)15 (Fig. 4A). Therefore in the sensor line, bantam miRNA binds to the target sequence at the 3′ end of the trans gene and blocks EGFP expression. Similar to earlier report15 the expression was clearly found in the larval wing discs, a tissue mass that develops into adult wings and proliferating brain cells. It is noted that bantam miRNA is expressed at all developmental stages in varying levels. To confirm the sensitivity of the transgenic stocks we performed Northern blot analysis by isolating total RNA from larvae of different lines. In wild type larvae, a bantam RNA of 21 nt long was expressed normally whereas in bantam sensor transgenic line, pre microRNA (70 nt) and processed mature microRNA (21 nt) were enriched. Interestingly feeding of DCPTN-PT compound to the same bantam sensor larvae did not produce even a trace amount of mature bantam RNA. The transfer RNA (tRNA) in each lane of the Northern hybridization was used as a gel loading control (Fig. 4B). This confirmed that continuous feeding of DCPTN-PT to Drosophila larvae misprocesses the synthesis of bantam oncomiRNA.
We also performed a series of rescue assays by feeding DCPTN-PT to bantam sensor and bantam∆1 transgenic stocks. The deleted (bantam∆1) homozygous pupae lack some or all imaginal discs and show undergrowth. Continuous feeding of DCPTN-PT to bantam sensor showed normal growth of homozygous adult and pupae relative to unfed bantam∆1 mutants (Fig. 4C). The bantam sensor expresses EGFP protein in adult flies.
The HDAC inhibitor, DCPTN-PT was further tested against the bantam miRNA, by feeding to control, sensor and mutant transgenic larvae. The level of EGFP expression in larval wing discs was observed. Low EGFP expression compared to control was observed in DCPTN-PT unfed sensor and larval discs (Fig. 5). Interestingly, EGFP expression was strongly increased upon feeding in bantam sensor lines. No change in EGFP expression was seen upon feeding of the same compound neither in control sensor nor in the mutant bantam∆1 lines (Fig. 5). Therefore DCPTN-PT not only acts as a HDAC inhibitor but also reduces bantam oncomiRNA activity simultaneously to increase EGFP expression in the larva of sensor line. In other words, DCPTN-PT feeding blocks bantam oncomiRNA production in the wing discs, enhancing the EGFP expression.
Hid expression and apoptosis
Previous studies have shown that bantam miRNA has three independent targets in 3′UTR of the apoptosis-inducing gene head involution defect (hid)15. The conservation of these sequences suggests a functional relationship between bantam miRNA and target gene hid. Continuous feeding of DCPTN-PT compound misprocesses the normal bantam mature microRNA biogenesis. Defective biogenesis reduces bantam microRNA production. Therefore, less bantam miRNA production may not be sufficient to bind to 3′ end of the target gene hid, thereby leading to translational blockage for the production of Hid protein significantly.
To assess whether there is an effect on the hid gene, we fed the compound to transgenic larvae that contained predicted bantam target sites (tubulin-EGFP reporter transgene fused to the 3′UTR on the hid mRNA). The resulting EGFP pattern observed in the wing disc was identical to that produced by the bantam sensor. Similar to bantam sensor, tubulin-EGFP-hid3′UTR sensor showed an immense up regulation of EGFP expression, when larvae were fed with DCPTN-PT (12 μM in 3 ml of food) containing culture media (Fig. 6A). It demonstrated that feeding of DCPTN-PT blocked the production of mature bantam oncomiRNA and leads to hid up regulation. Thus bantam miRNA can block expression of a transgene containing the hid 3′ UTR in tubulin-EGFP reporter.
To analyse the effect on adult stage DCPTN-PT containing culture media was fed to transgenic larvae that carry a Glass Multimer Report (GMR) promoter fused to hid and allowed them to grow into adult flies. GMR promoter is particularly expressed in eye and eye precursor tissues (imaginal disc). This unique stock carrying an eye specific promoter allows any modulation of the specific pathway to be visualised with the change of eye phenotype15. Induction of cell death in post mitotic cells of the eye imaginal disc in GMR hid transgene flies produced small rough eye phenotype in adults15. The eye size was further reduced after continuous feeding with DCPTN-PT containing culture media to the larvae that developed into adults indicating a dramatic increase of apoptosis. Moreover, ommatidital structure was largely irregular and drastically reduced. Interestingly no distortion was found in the eye phenotype and ommatidial structure of adult flies that emerged from bantam∆1 (stock in which the bantam microRNA sequences were totally deleted) larvae fed with DCPTN-PT containing culture media (Fig. 6B). To further reconfirm the specificity of the molecule on hid induced apoptosis in the adult flies of GMR-hid lines, we fed the same concentration of the compound to another transgenic line GMR-hid (Ala5) that contains 5 conserved Extracellular Signal Regulated Kinase (ERK) phosphorylation sites mutated to alanine15 and thereby unable to suppress the activation of the ERK-Mitogen-activated Protein Kinase (MAPK) pathway35. This transgenic line induces cell death in post mitotic cells in adult eye producing small rough eye phenotype. Continuous feeding of the compound to larvae of GMR-hid (Ala5) did not produce any change in the size of the eye phenotype nor ommatidial arrangements or structures (Fig. 6C). Though both the transgenes GMR-hid and GMR-hid (Ala5) lead small rough eye phenotype, suppression of the GMR-hid is stronger than GMR-hid (Ala5) (Fig. 6C). The ommatidial structure was largely reduced by continuous feeding of compound in GMR-hid but not in the GMR-hid (Ala5). It suggests a more specific increment of endogenous hid activity and DCPTN-PT molecules cannot activate endogenous hid by the common ERK-MAPK pathway.
To further address the issue whether misregulation of bantam by the DCPTN-PT up regulate endogenous hid expression in larvae, a quantitative Western blot analysis was performed with different genotypes. In control and bantam sensor larvae hid expression was relatively less when compared to the expression seen in larvae fed with DCPTN-PT at two different concentrations. Thus expression of endogenous hid was up regulated upon feeding the compound leading to over expression of the HID proteins. To eliminate the oversaturation of Western blot hybridization we also used low concentration of compound (2 μM) in the quantitative western blot analysis. A similar trend of over expression of the target protein was observed after feeding the compounds at two different concentrations indicating that oversaturation of the gel blots do not interfere the over expression.
Though there was a significant increment in the production of HID proteins by the reduction of bantam miRNA, as a result of continuous feeding of DCPTN-PT molecules, there was no change in the hid mRNA expression (Fig S5). This indicates that the over expression of the HID protein due to repression of bantam miRNA is probably due to reduction in the translation blockage of the hid mRNA.
In search of whether misregulation of bantam miRNA is a general defect of microRNA processing or specific for bantam, we have estimated the amount of core genes that are involved in microRNA processing. Earlier it was found that Dicer-1 in Drosophila, which is supposed to cleave the mature microRNAs, has no effect by its mutation to the modulation of all microRNAs. Based on such specificity, we can assume that DCPTN-PT might be affected only on bantam misexpression. To ensure that core microRNA processor genes were measured by quantitative RT PCR. It was found that DCPTN-PT compound and precursor trialzole compound has no significant effect on drosha and pasha RNA when S2 cells were incubated with two separate compounds (DCPTN-PT and precursor Triazole) (Fig. 6D). However their effect in Dicer1 transcripts is marginal but significant. These findings showed that the effect of DCPTN-PT is very specific and can be potent candidate for bantam regulated process.
Effect of DCPTN-PT in Mitochondrial pathway
We next estimated the protein levels of the known apoptotic marker, Caspase-3. Total proteins were extracted from both DCPTN-PT fed and unfed larvae and western blot analysis was performed with antibody against cleaved Caspase-3. The level of apoptotic proteins increased considerably upon feeding when compared to unfed controls (Fig. 7A,B).
Two main classes of apoptosis are the mitochondrial extrinsic and intrinsic pathways. Both involve caspase activation that lead to the cleavage of multiple intracellular substrates. To address that the activation of Caspase-3 also influences Drosophila intrinsic pathway, we estimated the protein level of Drosophila Bcl-2 family, especially pro-apoptotic protein DEBCL and Drosophila Poly ADP Ribose Polymerase (dPARP) another effector protein in the pathway, after continuous feeding of DCPTN-PT molecules to larvae. Continuous feeding of larvae with DCPTN-PT at two different concentrations significantly reduced the level of expression of both the proteins DEBCL and dPARP relative to the triazole fed and unfed larvae (Fig. 7A,B). The Bcl-2 family proteins and PARP are highly conserved throughout evolution36. To ensure that DCPTN-PT molecules produce similar effect in mammalian cell lines; we performed the same experiment after incubating HeLa cells with DCPTN-PT molecules. A similar trend was found (Fig. S6) indicating that incubation of DCPTN-PT in two different organisms does not causes any effect on the conserved homology among species.
We identified a novel function of a newly synthesized triazole derivative that reduces drastically a critical oncomiRNA from bantam coded gene responsible for promoting cell proliferation and blocking apoptosis15. Mode of action of DCPTN-PT molecule in depth was evaluated functionally. The misexpression of proto-oncomiRNA, bantam might be responsible for diseases of cell proliferation that inhibit programmed cell death in Drosophila and vertebrates. The DCPTN-PT dependent misregulation of bantam microRNA reduces tissue growth unlike bantam∆1.
To investigate how misprocessing of bantam microRNA would promote cell death and prevent rapid cell division, it is necessary to determine it’s down regulatory genes. It was shown that bantam microRNA control pro-apoptotic gene hid directly15. In this study, it is found that DCPTN-PT acts as a negative regulator for bantam microRNA that reduces mature miRNA dramatically and increases target protein level (as HID) that might be a positive regulator of cell apoptosis or cell death. The reduction of bantam microRNA by the continuous feeding of DCPTN-PT may not be sufficient at the 3′ UTR endogenous binding of the hid locus. As a result, Hid proteins increase in amount by breaking bantam miRNA translation blockage of hid 3′ UTR. We also found that DCPTN-PT affects mitochondrial apoptotic pathways of Drosophila and mammalian cell lines. It suggests that DCPTN-PT orchestrates multifactor aspects of apoptosis, apart from degradation of bantam microRNA prominently, but also affects mitochondrial apoptotic pathway. It therefore seems likely that DCPTN-PT may reduce bantam oncomiRNA through hid mRNA and a yet to be identified positive regulator of cell death via Caspase-3 dependent pathway. In depth characterization of DCPTN-PT will show additional predicted targets that determine how bantam regulates apoptosis.
It is noteworthy that triazole analogues stimulate programmed cell death and pattern formation. This also provides a unique in vivo platform for screening molecules that interfere with micro RNA pathway.
In conclusion an in-depth chemical in vivo screening method was been developed that not only identifies small molecules as a defective microprocessor of oncomiRNA, but also classifies their elaborate biological functions in cell and development pathways. Here changes in bantam activity introduced by triazole analogues developmentally up regulated programmed cell death in model organism (Fig. 8). Therefore, small molecules can function as unique modulator for understanding the role in misprocessing of cell proliferating miRNA and enhance apoptosis that probably open a new door for alternate use of natural chemical for regulating oncomiRNA.
In higher animals many programmed cell deaths are characterized by cell apoptosis. However DCPTN-PT fills a significant gap in our understanding of the caspase dependent apoptosis. In particular we have less information concerning how Caspases initiate membrane changes that are required for phagocytosis of the dying cells, further experiments would help us to unravel the understanding of how cells coordinate and shape the response to the disposal of dying cells. However DCPTN-PT molecules restrict their function to determine the Caspase participation in other cellular events such as differentiation and pattern formation. It also proposed that DCPTN-PT provide a positive link between the apoptotic mechanism that regulates patterning and tissue growth during animal development.
Total RNA was resolved on 15% denaturing acrylamide gels and hybridized with 5′ end labelled oligonucleotide probes as follows. A tRNA probe was used as a loading control as described  Drosophila bantam 5′ end labelling probe ACAAGTGAGATCATTTTGAAAGCTGATTTTGT.
For Western blot, freshly dissected wing imaginal discs were homogenized in lysis buffer [6% SDS, 1 mM EDTA, 2 mM PMSF, 10 μg/ml Aprotinin, 10 μg/ml Leupeptin, 10 μg/ml Pepstatin] and boiled at 95 °C for 5 minutes. Total protein was isolated and estimated using Bradford assay. Quantitative Western blot analysis was carried out using anti-rabbit EGFP (1:1000), Hid (1:500), cleaved caspase 3 (1:1000) antibodies. The blots were re-probed with anti-mouse ß-Actin (1:2000) as a gel loading control. For Histone estimation Histone 1, 2, 4, 8 (1:1000) antibodies were used. For loading control, Histone 3 (1:2000) dilution was used. For quantitative Western blot analysis from untreated and treated cell lines, total proteins were extracted from 5–10 × 105 HeLa cells. Hybridization was conducted with mammalian Cleaved PARP (1:1000 dilution) Full length PARP (1:1250), Active caspase-3 (1:1500) Caspase 9 (1:1000). Cytochrome c (1:1500), Bax (1:1000) and Bcl-2 (1:1000) antibodies. After washing, the blots were incubated with secondary antibodies conjugated to horseradish-peroxidase. Immunoreactive bands were detected by enhanced chemiluminescence (ECL). Membranes were stripped and incubated with anti-mouse ß-Actin (1:2000) antibody to ensure equal protein loading.
Real time PCR analysis
Total RNA was isolated by TRIzol® (Invitrogen, USA) method. RNA concentration & purity were measured by Nanodrop. RNA clean up and DNase treatment were performed to get DNA free pure RNA. cDNA was synthesized using DNase-treated pure total RNA. Real-time RT-PCR analyses were carried out using Applied Biosystem Power SYBR® Green PCR Master Mix in 7900HT Fast Real-Time PCR System (Applied Biosystem, USA). Reaction mixture was prepared using following components (reaction volume –20 μl)—6 μl PCR-H2O, 1 μl forward primer (0.5 μM), 1 μl reverse primer (0.5 μM), 10 μl Power SYBR® Green PCR Master Mix and as a template 2 μl cDNA (50 ng) was added. Using the following protocol amplification and quantification procedure were carried out- Initial denaturation (95 °C for 1 min), amplification and quantification program repeated 40 cycles (95 °C for 10 s, 58 °C for 10 s, 72 °C for 20 s with each step fluorescence measurement mode), melting curve program (55 °C–95 °C) and finally cooling to 40 °C.
The following primers were used for amplification
RT-Forward primer—5′ TTCCTGCCCTCTTTCTTTG 3′
RT-Reverse Primer—5′ GTCCTTATCCGCTTCCTTCC 3′
18s RNA primers
Forward: 5′- CCTTATGGGACGTGTGCTTT -3′
Reverse: 5′- CCTGCTGCCTTCCTTAGATG -3′
How to cite this article: Bhadra, U. et al. HDAC inhibitor misprocesses bantam oncomiRNA, but stimulates hid induced apoptotic pathway. Sci. Rep. 5, 14747; doi: 10.1038/srep14747 (2015).
Kitajima, K., Yamasaki, E., Kaji, Y., Murakami, K. & Sugimura, K. Comparison of DWI and PET/CT in evaluation of lymph node metastasis in uterine cancer. World Journal of Radiology 4, 207–214 (2012).
Zhang, S., Wu, L., Liu, Q., Chen, K. & Zhang, X. Impact on growth and invasion of gastric cancer cell lines by silencing NEDD9. Onco Targets Therapy 8, 223–231 (2015).
Brambert, P. R. et al. DNMT3B7 Expression Promotes Tumor Progression to a More Aggressive Phenotype in Breast Cancer Cells. PloS One 10, e0117310 (2015).
Belinsky, S. A. Unmasking the lung cancer epigenome. Annual Review of Physiology 77, 453–474 (2015).
Blandino, G., Shaul, Y., Strano, S., Sudol, M. & Yaffe, M. The Hippo tumor suppressor pathway: a brainstorming workshop. Science Signaling 2, mr6 (2009).
Zhang, W. & Cohen, S. M. The Hippo pathway acts via p53 and microRNAs to control proliferation and proapoptotic gene expression during tissue growth. Biology Open 2, 822–828 (2013).
Zhao, B., Li, L., Lei, Q. & Guan, K. L. The Hippo-YAP pathway in organ size control and tumorigenesis: an updated version. Genes & Dev 24, 862–874 (2010).
Yu, F. X. & Guan, K. L. The Hippo pathway: regulators and regulations. Genes & Dev 27, 355–371 (2013).
Saucedo, L. J. & Edgar, B. A. Filling out the Hippo pathway. Nature Rev Mole Cell Biol 8, 613–621 (2007).
Huang, H. et al. Bantam is essential for Drosophila intestinal stem cell proliferation in response to Hippo signaling. Dev Biol 385, 211–219 (2014).
Huang, J., Wu, S., Barrera, J., Matthews, K. & Pan, D. The Hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the Drosophila Homolog of YAP. Cell 122, 421–434 (2005).
Nolo, R., Morrison, C. M., Tao, C., Zhang, X. & Halder, G. The bantam microRNA is a target of the hippo tumor-suppressor pathway. Curr Biol 16, 1895–1904 (2006).
Peng, H. W., Slattery, M. & Mann, R. S. Transcription factor choice in the Hippo signaling pathway: homothorax and yorkie regulation of the microRNA bantam in the progenitor domain of the Drosophila eye imaginal disc. Genes & Dev 23, 2307–2319 (2009).
Thompson, B. J. & Cohen, S. M. The Hippo pathway regulates the bantam microRNA to control cell proliferation and apoptosis in Drosophila. Cell 126, 767–774 (2006).
Brennecke, J., Hipfner, D. R., Stark, A., Russell, R. B. & Cohen, S. M. bantam encodes a developmentally regulated microRNA that controls cell proliferation and regulates the proapoptotic gene hid in Drosophila. Cell 113, 25–36 (2003).
Farazi, T. A., Juranek, S. A. & Tuschl, T. The growing catalog of small RNAs and their association with distinct Argonaute/Piwi family members. Development 135, 1201–1214 (2008).
Nishikura, K. A short primer on RNAi: RNA-directed RNA polymerase acts as a key catalyst. Cell 107, 415–418 (2001).
Bartel, D. P. MicroRNAs: genomics, biogenesis, mechanism and function. Cell 116, 281–297 (2004).
Ambros, V. et al. A uniform system for microRNA annotation. RNA 9, 277–279 (2003).
Kim, V. N. Small RNAs: classification, biogenesis and function. Mol Cells 19, 1–15 (2005).
Bernstein, E., Caudy, A. A., Hammond, S. M. & Hannon, G. J. Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature 409, 363–366 (2001).
Lagos-Quintana, M., Rauhut, R., Meyer, J., Borkhardt, A. & Tuschl, T. New microRNAs from mouse and human. RNA 9, 175–179 (2003).
Rodriguez, A., Griffiths-Jones, S., Ashurst, J. L. & Bradley, A. Identification of mammalian microRNA host genes and transcription units. Genome Res 14, 1902–1910 (2004).
Griffiths-Jones, S. miRBase: the microRNA sequence database. Methods Mol Biol 342, 129–138 (2006).
Griffiths-Jones, S. The microRNA Registry. Nucleic Acids Res 32, D109–111 (2004).
Griffiths-Jones, S., Saini, H. K., van Dongen, S. & Enright, A. J. miRBase: tools for microRNA genomics. Nucleic Acids Res 36, D154–158 (2008).
Cullen, B. R. Transcription and processing of human microRNA precursors. Mol Cell 16, 861–865 (2004).
Deiters, A. Small molecule modifiers of the microRNA and RNA interference pathway. AAPS J 12, 51–60 (2010).
Makarevic, J. et al. Cross-communication between histone H3 and H4 acetylation and Akt-mTOR signalling in prostate cancer cells. J Cell Mol Med 18, 1460–1466 (2014).
Bassett, S. A. & Barnett, M. P. G. The role of dietary histone deacetylases (HDACs) inhibitors in health and disease. Nutrients 6, 4273–4301 (2014).
Xu, W. S., Parmigiani, R. B. & Marks, P. A. Histone deacetylase inhibitors: molecular mechanisms of action. Oncogene 26, 5541–5552 (2007).
Chandrasekhar, S. et al. aza-Flavanones as potent cross-species microRNA inhibitors that arrest cell cycle. Bioorg Med Chem Lett 22, 645–648 (2012).
New, M., Olzscha, H. & La Thangue, N. B. HDAC inhibitor-based therapies: can we interpret the code? Mol Oncol 6, 637–656 (2012).
Hassan, O., Ahmad, A., Sethi, S. & Sarkar, F. H. Recent updates on the role of microRNAs in prostate cancer. J Hematol Oncol 5, 9 (2012).
Brand, A. H. & Perrimon, N. Targeted gene expression as a means of altering cell fates and generating dominant phenotypes. Development 118, 401–415 (1993).
Roberts, P. J. & Der, C. J. Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer. Oncogene 26, 3291–3310 (2007).
All authors thank Steven Cohen for generous gift of the bantam sensor, control sensor and bantamΔ1 stocks. UB thank CSIR 12th FYP (BSC-0121) and MPB thank CSIR 12th FYP SMiLE CSC0111 for funding the project. TM thanks CSIR for his fellowship and IB thanks CSIR for her post doctoral fellowship (CSIR Nehru Science PDF). All the authors thank Y. Suresh for the flow cytometry studies.
The authors declare no competing financial interests.
Electronic supplementary material
About this article
Cite this article
Bhadra, U., Mondal, T., Bag, I. et al. HDAC inhibitor misprocesses bantam oncomiRNA, but stimulates hid induced apoptotic pathway. Sci Rep 5, 14747 (2015). https://doi.org/10.1038/srep14747
Activation of β-Catenin Signaling and its Crosstalk With Estrogen and Histone Deacetylases in Human Uterine Fibroids
The Journal of Clinical Endocrinology & Metabolism (2020)
Novel Triazole linked 2-phenyl benzoxazole derivatives induce apoptosis by inhibiting miR-2, miR-13 and miR-14 function in Drosophila melanogaster
Identification and profiling of miRNAs in overwintering Lissorhoptrus oryzophilus via next-generation sequencing
Selective HDAC inhibitors with potent oral activity against leukemia and colorectal cancer: Design, structure-activity relationship and anti-tumor activity study
European Journal of Medicinal Chemistry (2017)
Molecular Medicine (2016)